119 related articles for article (PubMed ID: 9566719)
41. CD44 in colon cancer.
Herrlich P; Pals S; Ponta H
Eur J Cancer; 1995; 31A(7-8):1110-2. PubMed ID: 7577002
[TBL] [Abstract][Full Text] [Related]
42. Abnormal expression of CD44 variants in the exfoliated cells in the feces of patients with colorectal cancer.
Yamao T; Matsumura Y; Shimada Y; Moriya Y; Sugihara K; Akasu T; Fujita S; Kakizoe T
Gastroenterology; 1998 Jun; 114(6):1196-205. PubMed ID: 9609756
[TBL] [Abstract][Full Text] [Related]
43. Molecular detection of cancer cells by competitive reverse transcription-polymerase chain reaction analysis of specific CD44 variant RNAs.
Okamoto I; Morisaki T; Sasaki J; Miyake H; Matsumoto M; Suga M; Ando M; Saya H
J Natl Cancer Inst; 1998 Feb; 90(4):307-15. PubMed ID: 9486817
[TBL] [Abstract][Full Text] [Related]
44. Characterization of CD44v6 isoforms in head-and-neck squamous-cell carcinoma.
van Hal NL; van Dongen GA; Stigter-van Walsum M; Snow GB; Brakenhoff RH
Int J Cancer; 1999 Sep; 82(6):837-45. PubMed ID: 10446451
[TBL] [Abstract][Full Text] [Related]
45. Restricted patterns of CD44 variant exon expression in human papillary thyroid carcinoma.
Ermak G; Jennings T; Robinson L; Ross JS; Figge J
Cancer Res; 1996 Mar; 56(5):1037-42. PubMed ID: 8640758
[TBL] [Abstract][Full Text] [Related]
46. Prognostic value of CD44 splice variants in human stage III cervical cancer.
Kainz C; Kohlberger P; Tempfer C; Sliutz G; Gitsch G; Reinthaller A; Breitenecker G
Eur J Cancer; 1995 Sep; 31A(10):1706-9. PubMed ID: 7488429
[TBL] [Abstract][Full Text] [Related]
47. CD44v3 and v6 variant isoform expression correlates with poor prognosis in early-stage vulvar cancer.
Tempfer C; Sliutz G; Haeusler G; Speiser P; Reinthaller A; Breitenecker G; Vavra N; Kainz C
Br J Cancer; 1998 Oct; 78(8):1091-4. PubMed ID: 9792156
[TBL] [Abstract][Full Text] [Related]
48. CD44 isoforms containing exons V6 and V7 are differentially expressed on mitogenically stimulated normal and Epstein-Barr virus-transformed human B cells.
Kryworuckho M; Diaz-Mitoma F; Kumar A
Immunology; 1995 Sep; 86(1):41-8. PubMed ID: 7590880
[TBL] [Abstract][Full Text] [Related]
49. CD44 isoform expression in the diffuse neuroendocrine system. II. Benign and malignant tumors.
Komminoth P; Seelentag WK; Saremaslani P; Heitz PU; Roth J
Histochem Cell Biol; 1996 Dec; 106(6):551-62. PubMed ID: 8985743
[TBL] [Abstract][Full Text] [Related]
50. Overexpression of CD44 variant transcripts in rat transplantable thyroid carcinoma lines demonstrating lung metastasis.
Kitahori Y; Cho M; Konishi N; Ohshima M; Matsui E; Ohnishi T; Imai S; Hiasa Y
Int J Oncol; 1998 Sep; 13(3):505-11. PubMed ID: 9683785
[TBL] [Abstract][Full Text] [Related]
51. Expression of CD44 in normal human versus tumor endometrial tissues: possible implication of reduced expression of CD44 in lymph-vascular space involvement of cancer cells.
Fujita N; Yaegashi N; Ide Y; Sato S; Nakamura M; Ishiwata I; Yajima A
Cancer Res; 1994 Jul; 54(14):3922-8. PubMed ID: 7518345
[TBL] [Abstract][Full Text] [Related]
52. Importance of different CD44v6 expression in human gastric intestinal and diffuse type cancers for metastatic lymphogenic spreading.
Dämmrich J; Vollmers HP; Heider KH; Müller-Hermelink HK
J Mol Med (Berl); 1995 Aug; 73(8):395-401. PubMed ID: 8528741
[TBL] [Abstract][Full Text] [Related]
53. [Expression of CD44 in endometrial cancer and metastasis].
Fujita N; Sato S
Nihon Rinsho; 1995 Jul; 53(7):1716-20. PubMed ID: 7630013
[TBL] [Abstract][Full Text] [Related]
54. Fab-conjugated PLGA nanoparticles effectively target cancer cells expressing human CD44v6.
Kennedy PJ; Sousa F; Ferreira D; Pereira C; Nestor M; Oliveira C; Granja PL; Sarmento B
Acta Biomater; 2018 Nov; 81():208-218. PubMed ID: 30267881
[TBL] [Abstract][Full Text] [Related]
55. CD44 exon variant 6 epitope and hyaluronate synthase are expressed on HT29 human colorectal carcinoma cells in a SCID mouse model of metastasis formation.
Mitchell BS; Whitehouse A; Prehm P; Delpech B; Schumacher U
Clin Exp Metastasis; 1996 Mar; 14(2):107-14. PubMed ID: 8605724
[TBL] [Abstract][Full Text] [Related]
56. The prognostic value of CD44 isoforms in prostate cancer patients treated by radical prostatectomy.
Noordzij MA; van Steenbrugge GJ; Verkaik NS; Schröder FH; van der Kwast TH
Clin Cancer Res; 1997 May; 3(5):805-15. PubMed ID: 9815753
[TBL] [Abstract][Full Text] [Related]
57. Expression of CD44 variant exons 8-10 in colorectal cancer and its relationship to metastasis.
Takeuchi K; Yamaguchi A; Urano T; Goi T; Nakagawara G; Shiku H
Jpn J Cancer Res; 1995 Mar; 86(3):292-7. PubMed ID: 7538103
[TBL] [Abstract][Full Text] [Related]
58. A directly spliced exon 10-containing CD44 variant promotes the metastasis and homotypic aggregation of aggressive non-Hodgkin's lymphoma.
Yakushijin Y; Steckel J; Kharbanda S; Hasserjian R; Neuberg D; Jiang W; Anderson I; Shipp MA
Blood; 1998 Jun; 91(11):4282-91. PubMed ID: 9596677
[TBL] [Abstract][Full Text] [Related]
59. Expression of CD44 variant 6 and its prognostic value in benign and malignant endometrial tissue.
Kansu-Celik H; Gungor M; Ortac F; Kankaya D; Ensari A
Arch Gynecol Obstet; 2017 Aug; 296(2):313-318. PubMed ID: 28620808
[TBL] [Abstract][Full Text] [Related]
60. Differential expression of the human metastasis adhesion molecule CD44V in normal and carcinomatous stomach mucosa of Chinese subjects.
Harn HJ; Ho LI; Chang JY; Wu CW; Jiang SY; Lee HS; Lee WH
Cancer; 1995 Mar; 75(5):1065-71. PubMed ID: 7531611
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
